In the News September 25, 2023

Associated Press | Experimental Treatment Pushed by ALS Patients Gets Day Before FDA, but Agency Unconvinced It Works

Marc Scheineson is quoted on the FDA’s consideration of an experimental treatment for Lou Gehrig’s disease.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.